These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 10811294

  • 1. IgG1 is the dominant subclass of antibody against glutamic acid decarboxylase among type 1 diabetes in Japanese.
    Kasuga A, Shimada A, Ozawa Y, Maruyama T, Oya K, Saruta T.
    Endocr J; 2000 Feb; 47(1):57-62. PubMed ID: 10811294
    [Abstract] [Full Text] [Related]

  • 2. IgG subclass antibodies to glutamic acid decarboxylase and risk for progression to clinical insulin-dependent diabetes.
    Couper JJ, Harrison LC, Aldis JJ, Colman PG, Honeyman MC, Ferrante A.
    Hum Immunol; 1998 Aug; 59(8):493-9. PubMed ID: 9712353
    [Abstract] [Full Text] [Related]

  • 3. The glutamic acid decarboxylase 65 immunoglobulin G subclass profile differs between adult-onset type 1 diabetes and latent autoimmune diabetes in adults (LADA) up to 3 years after clinical onset.
    Hillman M, Törn C, Landin-Olsson M, DISS study group.
    Clin Exp Immunol; 2009 Aug; 157(2):255-60. PubMed ID: 19604265
    [Abstract] [Full Text] [Related]

  • 4. IgG4-subclass of glutamic acid decarboxylase antibody is more frequent in latent autoimmune diabetes in adults than in type 1 diabetes.
    Hillman M, Törn C, Thorgeirsson H, Landin-Olsson M.
    Diabetologia; 2004 Nov; 47(11):1984-9. PubMed ID: 15565370
    [Abstract] [Full Text] [Related]

  • 5. Immune responses to glutamic acid decarboxylase and insulin in patients with gestational diabetes.
    Füchtenbusch M, Bonifacio E, Lampasona V, Knopff A, Ziegler AG.
    Clin Exp Immunol; 2004 Feb; 135(2):318-21. PubMed ID: 14738462
    [Abstract] [Full Text] [Related]

  • 6. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice.
    Bonifacio E, Atkinson M, Eisenbarth G, Serreze D, Kay TW, Lee-Chan E, Singh B.
    Diabetes; 2001 Nov; 50(11):2451-8. PubMed ID: 11679421
    [Abstract] [Full Text] [Related]

  • 7. Characteristics of in-vitro phenotypes of glutamic acid decarboxylase 65 autoantibodies in high-titre individuals.
    Chéramy M, Hampe CS, Ludvigsson J, Casas R.
    Clin Exp Immunol; 2013 Mar; 171(3):247-54. PubMed ID: 23379430
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical and genetic characteristics of people with type 1 diabetes who have discrepancies in titers of anti-glutamic acid decarboxylase antibody measured by radioimmunoassay and enzyme-linked immunosorbent assay.
    Takagi S, Miura J, Hoshina S, Uchigata Y, Babazono T.
    J Diabetes Investig; 2020 Mar; 11(2):356-362. PubMed ID: 31267698
    [Abstract] [Full Text] [Related]

  • 10. Protein tyrosine phosphatase-like protein IA2-antibodies plus glutamic acid decarboxylase 65 antibodies (GADA) indicates autoimmunity as frequently as islet cell antibodies assay in children with recently diagnosed diabetes mellitus.
    Borg H, Fernlund P, Sundkvist G.
    Clin Chem; 1997 Dec; 43(12):2358-63. PubMed ID: 9439455
    [Abstract] [Full Text] [Related]

  • 11. GAD-alum treatment in patients with type 1 diabetes and the subsequent effect on GADA IgG subclass distribution, GAD65 enzyme activity and humoral response.
    Chéramy M, Skoglund C, Johansson I, Ludvigsson J, Hampe CS, Casas R.
    Clin Immunol; 2010 Oct; 137(1):31-40. PubMed ID: 20580618
    [Abstract] [Full Text] [Related]

  • 12. Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly-progressive type 1 diabetes.
    Kawasaki E, Awata T, Ikegami H, Imagawa A, Oikawa Y, Osawa H, Katsuki T, Kanatsuna N, Kawamura R, Kozawa J, Kodani N, Kobayashi T, Shimada A, Shimoda M, Takahashi K, Chujo D, Tsujimoto T, Tsuchiya K, Terakawa A, Terasaki J, Nagasawa K, Noso S, Fukui T, Horie I, Yasuda K, Yasuda H, Yanai H, Hanafusa T, Kajio H, Japanese Type 1 Diabetes Database Study (TIDE‐J).
    J Diabetes Investig; 2024 Jul; 15(7):835-842. PubMed ID: 38451108
    [Abstract] [Full Text] [Related]

  • 13. Glutamic acid decarboxylase autoantibodies are dominant but insufficient to identify most Chinese with adult-onset non-insulin requiring autoimmune diabetes: LADA China study 5.
    Xiang Y, Huang G, Shan Z, Pan L, Luo S, Yang L, Shi L, Li Q, Leslie RD, Zhou Z.
    Acta Diabetol; 2015 Dec; 52(6):1121-7. PubMed ID: 26239144
    [Abstract] [Full Text] [Related]

  • 14. IgG4 subclass glutamic acid decarboxylase antibodies (GADA) are associated with a reduced risk of developing type 1 diabetes as well as increased C-peptide levels in GADA positive gestational diabetes.
    Dereke J, Nilsson C, Strevens H, Landin-Olsson M, Hillman M.
    Clin Immunol; 2016 Jan; 162():45-8. PubMed ID: 26548838
    [Abstract] [Full Text] [Related]

  • 15. Detection of Antibodies Directed to the N-Terminal Region of GAD Is Dependent on Assay Format and Contributes to Differences in the Specificity of GAD Autoantibody Assays for Type 1 Diabetes.
    Williams AJ, Lampasona V, Schlosser M, Mueller PW, Pittman DL, Winter WE, Akolkar B, Wyatt R, Brigatti C, Krause S, Achenbach P, Participating Laboratories.
    Diabetes; 2015 Sep; 64(9):3239-46. PubMed ID: 25972570
    [Abstract] [Full Text] [Related]

  • 16. Glutamic acid decarboxylase 65 autoantibody levels discriminate two subtypes of latent autoimmune diabetes in adults.
    Li X, Yang L, Zhou Z, Huang G, Yan X.
    Chin Med J (Engl); 2003 Nov; 116(11):1728-32. PubMed ID: 14642146
    [Abstract] [Full Text] [Related]

  • 17. Immunoglobulin subclass profiles of anti-idiotypic antibodies to GAD65Ab differ between type 1 diabetes patients and healthy individuals.
    Oak S, Radtke J, Törn C, Landin-Olsson M, Hampe CS.
    Scand J Immunol; 2011 Oct; 74(4):363-7. PubMed ID: 21517929
    [Abstract] [Full Text] [Related]

  • 18. Actual condition survey regarding mismatch of measurements between radioimmunoassay and enzyme-linked immunosorbent assay tests for anti-glutamic acid decarboxylase antibody in real-world clinical practice.
    Oikawa Y, Kondo T, Shimada A, Seino Y, Kitaoka M.
    J Diabetes Investig; 2019 May; 10(3):685-689. PubMed ID: 30307126
    [Abstract] [Full Text] [Related]

  • 19. Exposure to exogenous insulin promotes IgG1 and the T-helper 2-associated IgG4 responses to insulin but not to other islet autoantigens.
    Füchtenbusch M, Kredel K, Bonifacio E, Schnell O, Ziegler AG.
    Diabetes; 2000 Jun; 49(6):918-25. PubMed ID: 10866043
    [Abstract] [Full Text] [Related]

  • 20. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
    Seissler J, Morgenthaler NG, Achenbach P, Lampeter EF, Glawe D, Payton M, Christie M, Scherbaum WA.
    Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.